El-KholyAA, ElananyMG, SherifMM, GadMA. High prevalence of VIM, KPC, and NDM expression among surgical site infection pathogens in patients having emergency surgery. Surg Infect, 2018; 19:629–633.
2.
Di CarloP, GulottaG, CasuccioA, et al.KPC-3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: Analysis of a case series of 330 patients. BMC Anesthesiol, 2013; 13:13.
3.
Mora-GuzmanI, Rubio-PerezI, Maqueda GonzalezR, et al.Surgical site infection by carbapenemase-producing Enterobacteriaceae. A challenge for today's surgeons (Spa). Cir Esp, 2020 21 Jan doi 10.1016/j/ciresp.2019.11.006 e-pub ahead of print
4.
OteoJ, OrtegaA, BartolomeR, et al.Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother, 2015; 59:3406–3412.
5.
BartschSM, McKinnellJA, MuellerLE, et al.Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect, 2017; 23:48 e9–e16.